Sodium Chloride NDC 0019-1188

NDC codes

FDA NDC Directory

Product NDC (as listed)0019-1188Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00019-1188Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0019-1188-27	00019118827	20 BOX in 1 CARTON (0019-1188-27) / 1 SYRINGE, PLASTIC in 1 BOX / 125 mL in 1 SYRINGE, PLASTICMarketed from Sep 1, 2012
0019-1188-81	00019118881	20 BOX in 1 CARTON (0019-1188-81) / 1 SYRINGE, PLASTIC in 1 BOX / 125 mL in 1 SYRINGE, PLASTICMarketed from Sep 1, 2012

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Sodium Chloride
Generic name (nonproprietary): sodium chloride
Active ingredients: Sodium chloride — .9 mg/mL
Dosage form: Injection
Route: Intravascular
Labeler: Liebel-Flarsheim Company LLC
Product type: Prescription drug
Marketing category: NDA — New Drug ApplicationApplication NDA 021569
Marketing start: Sep 1, 2012
Listing expires: Dec 31, 2026
Other FDA classes: Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)
Identifiers: Product ID 0019-1188_cdff7813-7b00-4f61-a017-18ab8910d49dSPL ID cdff7813-7b00-4f61-a017-18ab8910d49dSPL set ID e4540d03-06b4-4b4d-b859-75c13e5c20ddUNII 451W47IQ8XUPC 0300191188816
Pharmacologic class: Osmotic Laxative

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

NDC on a medical claim

N400019118827 followed by a unit qualifier and the quantity

Package 00019-1188-27. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Dec 20, 2022.

Indications (excerpt from the label)

125 mL Syringe: Sodium Chloride Injection USP 0.9% is indicated for use in flushing compatible contrast agents through Liebel-Flarsheim intravenous administration sets into indwelling intravascular access devices only when delivered by the following Liebel-Flarsheim power injectors: Angiomat ® , Illumena ® , Illumena ® Néo, CT9000 ® , CT9000 ® ADV, Optistat ® , Optivantage ® and Optistar Elite. For use in flushing compatible contrast agents through Liebel-Flarsheim intravenous administration sets into indwelling intravascular access devices ( 1 )

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)